Palliative care in the final days of life: "They were expecting it at any time"

JAMA

Volumn 293, Issue 18, 2005, Pages 2265-2271

  Hallenbeck, James ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LORAZEPAM; MORPHINE;

AGITATION; BACTERIAL INFECTION; BILE DUCT CARCINOMA; CASE REPORT; DOSE RESPONSE; DYSPNEA; FAMILY COUNSELING; HUMAN; INTENSIVE CARE; INTERPERSONAL COMMUNICATION; INTUBATION; MALE; MEDICAL ETHICS; MEDICAL PRACTICE; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ARTICLE; DOCTOR PATIENT RELATION; TERMINAL CARE;

HUMANS; PALLIATIVE CARE; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; TERMINAL CARE;

EID: 18244388950     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.18.2265     Document Type: Review

References (61)

1. Teno JM, Weitzen S, Fennell ML, Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med. 2001;4:457-464.
2. Christakis NA. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago, Ill: University of Chicago Press; 1999.
3. Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L. Oncologists' attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189-2196.
4. VandeKieft GK. Breaking bad news. Am Fam Physician. 2001;64:1975-1978.
5. Morita T, Akechi T, Ikenaga M, et al. Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol. 2004;15:1551-1557.
6. Hallenbeck J. Palliative Care Perspectives. New York, NY: Oxford University Press; 2003.
7. Morita T, Ichiki T, Tsunoda J, Inoue S, Chihara S. A prospective study on the dying process in terminally ill cancer patients. Am J Hosp Palliat Care. 1998;15:217-222.
8. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284:2476-2482.
9. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). A controlled trial to improve care for seriously ill hospitalized patients. JAMA. 1995;274:1591-1598.
10. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7-15.
11. Ellershaw J, Smith C, Overill S, Walker SE, Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage. 2001;21:12-17.
12. Hall P, Schroder C, Weaver L. The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc. 2002;50:501-506.
13. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88-93.
14. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care. 1990;6:7-11.
15. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990;5:83-93.
16. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7:5-11.
17. Conili C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997;14:328-331.
18. Fainsinger RL. Treatment of delirium at the end of life: medical and ethical issues. In: Portenoy RK, Bruera E, eds. Topics in Palliative Care. Vol 4. New York, NY: Oxford University Press; 1998:261-277.
19. Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med. 2000;16:357-372.
20. Lawlor P, Gagnon B. Occurrence, causes, and outcomes of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160:786-794.
21. Storey P. Symptom control in dying. In: Berger A, ed. Principles and Practice of Supportive Oncology. Philadelphia, PA: Lippincott-Raven; 1998:741-748.
22. O'Neill B, Fallon M. ABC of palliative care: principles of palliative care and pain control. BMJ. 1997;315:801-804.
23. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326:30-34.
24. Cherny NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995;76:1283-1293.
25. Herndon CM, Fike DS. Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage. 2001;22:1027-1034.
26. Chandler S. Nebulized opioids to treat dyspnea. Am J Hosp Palliat Care. 1999;16:418-422.
27. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990;5:341-344.
28. Mazzocato C, Buclin T, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 1999;10:1511-1514.
29. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321-340.
30. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939-944.
31. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20:403-417.
32. Watanabe S. The role of oxygen in cancer-related dyspnea. In: Portenoy R, Bruera E, eds. Topics in Palliative Care. Vol 4. New York, NV: Oxford University Press; 2000:255-260.
33. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage. 2002;24:447-453.
34. Rousseau P. Palliative sedation and sleeping before death: a need for clinical guidelines? J Palliat Med. 2003;6:425-427.
35. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001;21:282-289.
36. Morita T, Hirai K, Sakaguchi Y, Tsuneto S, Shima Y. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics. 2004;45:107-113.
37. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics. 2002;43:183-194.
38. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001;15:329-336.
39. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 2002;23:310-317.
40. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004;2:467-479.
41. Byock IR. Dying Well. New York, NY: Riverhead; 1997.
42. Byock IR. The Four Things That Matter Most. New York, NY: Free Press; 2004.
43. Hallenbeck J, Goldstein MK. Decisions at the end-of-life: cultural considerations beyond medical ethics. Generations. 1999Spring:24-29.
44. Marchand L, Kushner K. Death pronouncements: using the teachable moment in end-of-life care residency training. J Palliat Med. 2004;7:80-84.
45. Hallenbeck J, Katz S, Stratos G. End-of-Life Care Curriculum for Medical Teachers. Vol Module 3: Communicating with Patients and Families. Available at: http://www.growthhouse.org/stanford. Accessed March 14, 2005.
46. Koenig B. Cultural diversity in decisionmaking about care at the end of life. In: Field M, Cassel C, eds. Approaching Death: Improving Care at the End of Life (Institute of Medicine). Washington, DC: National Academy Press; 1997.
47. Hallenbeck J, Goldstein MK, Mebane EW. Cultural considerations of death and dying in the United States. Clin Geriatr Med. 1996;12:393-406.
48. Hallenbeck J. Cross-cultural issues. In: Berger A, Portenoy RK, Weissman DE, eds. Principles and Practice of Palliative Care and Supportive Oncology. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:661-672.
49. Pickett M. Cultural awareness in the context of terminal illness. Cancer Nurs. 1993;16:102-106.
50. Lo RS, Woo J, Zhoc KC, et al. Quality of life of palliative care patients in the last two weeks of life. J Pain Symptom Manage. 2002;24:388-397.
51. Puchalski CM. Spirituality and end-of-life care: a time for listening and caring. J Palliat Med. 2002;5:289-294.
52. Lynn J, Harrold J. Handbook for Mortals - Guidance for People Facing Serious Illness. New York, NY: Oxford University Press; 1999.
53. Schneiderman H, Gruhn J. How - and why - to request an autopsy. Postgrad Med. 1985;77:153-156.
54. McPhee SJ. Maximizing the benefits of autopsy for clinicians and families: what needs to be done. Arch Pathol Lab Med. 1996;120:743-748.
55. Sinard JH. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol. 2001;70:333-343.
56. Menkin E, Wolfson R, Weissman DE. Writing a condolence letter. End of Life/ Palliative Education Resource Center. Available at: http://www.eperc.mcw. edu. End of Life Education Project; 2000. Accessed March 14, 2005. Fast fact and concept No. 22.
57. Rando T, ed. Treatment of Complicated Mourning. Champaign, Ill: Research Press; 1993.
58. Zeitlin SV. Grief and bereavement. Prim Care. 2001;28:415-425.
59. Prigerson HG, Jacobs SC. Caring for bereaved patients: " all the doctors just suddenly go." JAMA. 2001;286:1369-1376.
60. Penson RT, Dignan FL, Canellos GP, Picard CL, Lynch TJ Jr. Burnout: caring for the caregivers. Oncologist. 2000;5:425-434.
61. Quill TE, Williamson PR. Healthy approaches to physician stress. Arch Intern Med. 1990;150:1857-1861.